Prominent adverse effects of thalidomide in primary Sjögren's syndrome

This publication has 9 references indexed in Scilit:

• Thalidomide: current and potential clinical applications
  Published by Elsevier ,2004
• Drug-induced systemic lupus erythematosus associated with etanercept therapy
  The Lancet, 2002
• Infliximab in patients with primary Sjögren's syndrome: A pilot study
  Arthritis & Rheumatism, 2001
• Sjögren's syndrome comes of age
  Seminars in Arthritis and Rheumatism, 1999
• An open study of pentoxyfylline and thalidomide as adjuvant therapy in the treatment of rheumatoid arthritis.
  Annals of the Rheumatic Diseases, 1996
• Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome.
  Annals of the Rheumatic Diseases, 1996
• Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet's disease: use of neurophysiological studies to detect thalidomide neuropathy.
  Annals of the Rheumatic Diseases, 1994
• Sjögren's syndrome. Proposed criteria for classification
  Arthritis & Rheumatism, 1986
• Thalidomide a promising new treatment for rheumatoid arthritis
  Arthritis & Rheumatism, 1984